Molecular biology of the chromaffin cell

Annals of the New York Academy of Sciences

Volumn 971, Issue , 2002, Pages 11-18

  Trifaró, José María ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Catecholamine synthesis; Chromogranins; Dopamine hydroxylase; Tyrosine hydroxylase

Indexed keywords

CHROMOGRANIN A; CHROMOGRANIN B; DOPAMINE BETA MONOOXYGENASE; GENE PRODUCT; PHENYLETHANOLAMINE N METHYLTRANSFERASE; SECRETOGRANIN II; TRANSCRIPTION FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; CATECHOLAMINE SYNTHESIS; CELL COMPARTMENTALIZATION; CHROMAFFIN CELL; CONFERENCE PAPER; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; PROMOTER REGION;

ANIMALIA;

EID: 0037024686     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04427.x     Document Type: Conference Paper

References (66)

1. Trifaro, J-M. 1977. Common mechanisms of hormone secretion. Annu. Rev. Pharmacol. Toxicol. 17: 27-47.
2. Trifaro, J-M. & A.M. Poisner. 1982. Common properties in the mechanisms of synthesis, processing and storage of secretory products. In The Secretory Process: Vol. 1, The Secretory Granule. A.M. Poisner & J-M. Trifaro, Eds.: 387-407. Elsevier/North Holland. Amsterdam.
3. Sudhof, T.C. & R. Jahn. 1991. Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron 6: 665-677.
4. Heinemann, C. et al. 1993. A two step model of secretion control in neuroendocrine cells. Pflugers Arch. 424: 105-112.
5. Neher, E. & R.S. Zucker. 1993. Multiple calcium-dependent processes related to secretion in bovine chromaffin cells. Neuron 10: 21-30.
6. Vitale, M.L. et al. 1995. Chromaffin cell cortical actin network dynamics control the size of the release-ready vesicle pool and the initial rate of exocytosis. Neuron 14: 353-363.
7. Vitale, M.L. et al. 1991. Cortical filamentous actin disassembly and scinderin redistribution during chromaffin cell stimulation precede exocytosis, a phenomenon not exhibited by gelsolin. J. Cell Biol. 113: 1057-1067.
8. Burgoyne, R.D. et al. 1982. Dissection of stages in exocytosis in the adrenal chromaffin cells with use of trifluoperazine. Proc. R. Soc. Lond. B 216: 111-115.
9. Rodriguez Del Castillo, A., et al. Chromaffin cell scinderin: A novel calcium-dependent actin filament severing protein. EMBO J. 6: 43-52.
10. 2+ -dependent F-actin severing proteins. Mol. Cell Biochem. 141: 153-165.
11. Sabban, E.L. & R. Kvetnansky. 2001. Stress-triggered activation of gene expression in catecholaminergic systems: Dynamics of transcriptional events. Trends Neurosci. 24: 91-98.
12. Blaschko, H. 1939. The specific action of L-Dopa decarboxylase. J. Physiol. 96: 50-51.
13. Axelrod, J. 1962. Purification and properties of phenylethanolamine N-methyltransferase. J. Biol. Chem. 237: 1657-1660.
14. Udenfriend, S. et al. 1953. Rate of turnover of epinephrine in the adrenal medulla. Science 117: 663-665.
15. Udenfriend, S. & J.B. Wyngaarden. 1956. Precursors of adrenal epinephrine and norepinephrine in vivo. Biochim. Biophys. Acta 20: 48-52.
16. Levitt, M. et al. 1965. Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J. Pharmacol. 148: 1-8.
17. Ikeda, M. et al. 1966. A kinetic study of bovine adrenal tyrosine hydroxylase. J. Biol. Chem. 241: 4452-4456.
18. Weiner, N. & M. Rabadjija. 1968. The regulation of norepinephrine synthesis. Effect of puromycin on the accelerated synthesis of norepinephrine associated with nerve stimulation. J. Pharmacol. Exp. Ther. 164: 103-114.
19. Zigmond, R.E. et al. 1989. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci. 12: 451-461.
20. Kumer, S.C. & K.E. Vrana. 1996. Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67: 443-462.
21. Muller, R.A. et al. 1969. Adrenal tyrosine hydroxylase: Compensatory increase in activity after chemical sympathectomy. Science 163: 468-469.
22. Patrick, R.L. & N. Kirshner. 1971. Effect of stimulation on the levels of tyrosine hydroxylase, dopamine β-hydroxylase and catecholamines in intact and denervated rat adrenal glands. Mol. Pharmacol. 7: 87-96.
23. Thoa, N.B. et al. Acceleration of catecholamine formation in the guinea-pig vas deferens following hypogastric nerve stimulation: Roles of tyrosine hydroxylase and new protein synthesis. J. Pharmacol. Exp. Ther. 178: 442-449.
24. Thoenen, H. et al. Trans-synaptic induction of adrenal tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 169: 249-264.
25. Fossom, L.H. et al. 1991. Stimulation of tyrosine hydroxylase gene transcription rate by nicotine in rat adrenal medulla. Mol. Pharmacol. 40: 193-202.
26. Wakade, A.R. & T.D. Wakade. 1983. Contribution of nicotinic and muscarinic receptors in the secretion of catecholamines evoked by endogenous and exogenous acetylcholine. Neuroscience 10: 973-978.
27. Malhorta, R.K. & A.R. Wakade. 1987. Non-cholinergic component of rat splanchnic nerves predominates at low neuronal activity and is eliminated by naloxone. J. Physiol. 383: 639-652.
28. Malhorta, R.K. et al. 1989. Cross-communication between acetylcholine and VIP in controlling catecholamine secretion by affecting cAMP, inositol trisphosphate, protein kinase C and calcium in the rat adrenal medulla. J. Neurosci. 9: 4150-4157.
29. Roskoski, R. & LM. Roskoski. 1989. Adenosine receptor activation and the regulation of tyrosine hydroxylase activity in PC12 and PC18 cells. J. Neurochem. 53: 1934-1940.
30. Haycock, J.W. & A.R. Wakade. 1992. Activation and multiple site phosphorylation of tyrosine hydroxylase in perfused rat adrenal glands. J. Neurochem. 58: 57-64.
31. Tank, A.W. et al. 1998. Regulation of tyrosine hydroxylase activity by muscarinic agonists in rat adrenal medulla. J. Pharmacol. Exp. Ther. 286: 848-854.
32. Piech-Dumas, K.M. & A.W. Tank. 1999. CREB mediates the cAMP-responsiveness of the tyrosine hydroxylase gene: Use of an antisense RNA strategy to produce CREB-deficient PC12 cell lines. Brain Res. Mol. Brain. Res. 70: 219-230.
33. Piech-Dumas, K.M. et al. 2001. The cAMP responsive element and CREB partially mediate the response of the tyrosine hydroxylase gene to phorbol ester. J. Neurochem. 76: 1376-1385.
34. Papanikolaou, N.A. & E.L. Sabban. 2000. Ability of Egrl to activate tyrosine hydroxylase transcription in PC12 cells. J. Biol. Chem. 275: 26683-26689.
35. Yang, C. et al. 1998. Identification and characterization of potential cis-regulatory elements governing transcriptional activation of the rat TH gene. J. Neurochem. 71: 1358-1368.
36. Cazorla, P. et al. 2000. A response element for the homeodomain transcription factor Ptx3 in the Th gene promoter. J. Neurochem. 74: 1829-1837.
37. McMhon, A. & E.L. Sabban. 1992. Regulation of expression of dopamine β-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues. J. Neurochem. 59: 2040-2047.
38. Nankova, B.B. et al. 1998. Selective in vivo stimulation of stress-activated protein kinase in different rat tissues by immobilization stress. Stress 2: 289-298.
39. Kirshner, N. & McM. Goodall. 1957. The formation of adrenaline from noradrenaline. Biochim. Biophys. Acta 24: 658-659.
40. Ross, M.E. et al. 1990. Identification of a functional glucocorticoid response element in the phenylethanolamine N-methyltransferase promoter using fusion genes introduced into chromaffin cells in primary cultures. J. Neurosci. 10: 520-530.
41. Ebert, S. et al. 1994. Egr-1 activation of rat adrenal phenylethanolamine N-methyltransferase gene. J. Biol. Chem. 269: 20885-20898.
42. Wong, D.L. 1998. Phenylethanolamine N-methyltransferase gene expression: Synergistic activation by Egr-1, AP-2 and the glucocorticoid receptor. Mol. Brain Res. 61: 154-161.
43. Morita, K. & D.L. Wong. 1996. Role of Egr-1 in cholinergic stimulation of phenylethanolamine N-metyltransferase promoter. J. Neurochem. 67: 1344-1351.
44. Tai, T.C. et al. 2001. Role of Egr-1 in cAMP-dependent protein kinase regulation of the phenyethanolamine N-methyltransferase gene. J. Neurochem. 76: 1851-1859.
45. Ebert, S.N. et al. 1998. Glucocorticoid-dependent action of neural crest factor AP-2: Stimulation of phenylethanolamine N-methyltranferase gene expression. J. Neurochem. 70: 2286-2295.
46. Aardal, S. & K.B. Helle. 1992. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul. Pept. 41: 9-18.
47. Helle, K.B. et al. 1993. Chromogranin A: Secretion of precessed products from the stimulated retrogradely perfused bovine adrenal gland. J. Neuroendocrinol. 5: 413-420.
48. Hutton, J.C. et al. 1987. Biosynthesis of betagranin in pancreatic beta cells. Identification of a chromogranin A-like precursor and its parallel processing with proinsulin. Biochem. J. 244: 449-456.
49. Drees, B.M. & J.W. Hamilton. 1994. Processing of chromogranin A by bovine parathyroid secretory granules: Production and secretion of N-terminal fragments. Endocrinology 134: 2057-2063.
50. Tatemoto, K. et al. 1986. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324: 476-478.
51. Fasciotta, B.H. et al. 1993. Parastatin (porcine chromogranin A 347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. Endocrinology 133: 461-466.
52. Galindo, E. et al. 1991. Chromostatin, a 20 amino acid peptide derived from chromogranin A, inhibits chromaffin secretion. Proc. Natl. Acad. Sci. USA 88: 1426-1430.
53. Taupenot, L. et al. 2000. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A (352-372) with the chromaffin cell surface and Torpedo electroplax: Implications for nicotinic cholinergic receptor antagonism. Regul. Pept. 95: 9-17.
54. Parmer, R.J. et al. 2000. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. J. Clin. Invest. 106: 907-915.
55. Rosa, P. & A. Zanini. 1981. Characterization of adenohypophysial polypeptides by two-dimensional gel electrophoresis. II. Sulfated and glycosylated polypeptides. Mol. Cell Endocrinol. 24: 181-193.
56. Rosa, P. & H.H. Gerdes. 1994. The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors. J. Endocrinol. Invest. 17: 207-225.
57. Saria, A. et al. 1993. Secretoneurin releases dopamine from rat striatal slices: A biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience 54: 1-4.
58. Schimmel, A. et al. 1992. The organization of the mouse secretogranin II gene. FEBS Lett. 314: 375-380.
59. Pohl, T.M. et al. 1990. The organization of the mouse chromogranin B (secretogranin I) gene. FEBS Lett. 262: 219-224.
60. Wu, H.J. et al. 1991. Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression. J. Biol. Chem. 266: 13130-13134.
61. Wu, H. et al. 1995. A functional cyclic AMP response element plays a crucial role in neuroendocrine cell-type specific expression of the secretory granule chromogranin A. J. Clin. Invest. 96: 568-578.
62. Tang, K. et al. 1996. Stimulus-transcription coupling in pheochromocytoma cells Promoter region-specific activation of chromogranin A biosynthesis. J. Biol. Chem. 271: 28382-28390.
63. Mahata, S.K. et al. 1999. Neurotropin activation of catecholamine storage vesicle protein gene expression: Signaling to chromogranin A biosynthesis. Neuroscience 88: 405-424.
64. Taupenot, L. et al. 1998. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP). J. Clin. Invest. 101: 863-876.
65. Mahapatra, N.R. et al. 2000. Neuroendocrine cell type-specific and inducible expression of the chromogranin B gene: Crucial role of the proximal promoter. Endocrinology 141: 3668-3678.
66. Mahata, S.K. et al. 1999. Neuroendocrine cell type-specific and inducible expression of the secretogranin II gene: Crucial role of cyclic adenosine monophosphate and serum response elements. Endocrinology 140: 739-749.